← All DO Flashcard Decks

Pharmacology and Therapeutics Flashcards

6 cards from real DO practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.

Read the first 6 Pharmacology and Therapeutics flashcards as text
  1. Which class of medications is first-line for managing hypertension in a patient with concurrent type 2 diabetes and proteinuria?

    Answer: ACE inhibitors or ARBs

    ACE inhibitors and ARBs are first-line in diabetic patients with proteinuria because they reduce intraglomerular pressure and slow nephropathy progression.

  2. A patient taking warfarin is started on rifampin. How should warfarin dosing be adjusted?

    Answer: Increase warfarin dose; rifampin induces CYP450 enzymes

    Rifampin is a potent CYP450 inducer that accelerates warfarin metabolism, reducing its anticoagulant effect and requiring a higher dose.

  3. Which antibiotic class is associated with QT prolongation and must be used cautiously in patients on antiarrhythmics?

    Answer: Fluoroquinolones

    Fluoroquinolones (e.g., ciprofloxacin, levofloxacin) can prolong the QT interval, increasing the risk of torsades de pointes especially with other QT-prolonging drugs.

  4. Metformin is contraindicated in patients with an eGFR below what threshold due to risk of lactic acidosis?

    Answer: 30 mL/min/1.73m²

    Metformin should be discontinued when eGFR falls below 30 mL/min/1.73m² because reduced renal clearance allows metformin accumulation and lactic acid buildup.

  5. Which opioid analgesic is safest to use in patients with chronic kidney disease because it lacks active renally cleared metabolites?

    Answer: Fentanyl

    Fentanyl is metabolized to inactive compounds and does not accumulate in renal failure, making it safer than morphine whose active metabolite (M6G) can cause toxicity.

  6. Statins exert their primary lipid-lowering effect by inhibiting which enzyme?

    Answer: HMG-CoA reductase

    Statins competitively inhibit HMG-CoA reductase, the rate-limiting enzyme in hepatic cholesterol synthesis, reducing LDL-C levels.

How this page was made: written with AI tools and published by Nathan Beja, founder of Practice Test Geeks, who is responsible for its content. Exam facts are checked against the official sources listed below. Not reviewed by a subject-matter expert. Editorial policy

Sources & references

Exam facts on this page (fees, format, dates, passing scores) are checked against these official sources; the date is our last check. Editorial policy

  1. nbome.org — Registration, passing score, exam format, time limit, fees, eligibility, test delivery, exam information · verified Nov 2026